can semaglutide cause high cholesterol Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study Cholesterol, heart health, and GLP-1

These medications can help lower blood sugar and promote weight loss

The specific mechanisms encompass three key aspects

Start your intake When Did GLP-1 Medications First Enter Clinical Use

Wellness Without Overclaiming We position B12 as wellness support, not as a guaranteed fix or treatment for disease

At Novo Nordisk, our goal is to provide innovative therapies that support healthier lives for people living with obesity, and we look forward to launching Wegovy HD to help even more people reach their weight and health goals. Novo Nordisk expects to launch Wegovy HD in a single-dose pen in the US in April 2026